Meprobamate (Alembic Pharmaceuticals Inc.)


Welcome to the PulseAid listing for the Meprobamate drug offered from Alembic Pharmaceuticals Inc.. This pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Alembic Pharmaceuticals Inc.
NON-PROPRIETARY NAME: Meprobamate
SUBSTANCE NAME: MEPROBAMATE
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS:
ROUTE: ORAL
DOSAGE FORM: TABLET
MARKETING CATEGORY NAME: ANDA
START MARKETING DATE: 2016-03-31
END MARKETING DATE: 0000-00-00


Meprobamate HUMAN PRESCRIPTION DRUG Details:

Item DescriptionMeprobamate from Alembic Pharmaceuticals Inc.
LABELER NAME: Alembic Pharmaceuticals Inc.
DEA SCHEDULE: CIV
ACTIVE STRENGTH: 200(mg/1)
START MARKETING DATE: 2016-03-31
END MARKETING DATE: 0000-00-00
PRODUCT ID: 62332-019_2f83665d-f4a7-4503-ab05-e34be087fc3e
PRODUCT NDC: 62332-019
APPLICATION NUMBER: ANDA090122

Other MEPROBAMATE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Alembic Pharmaceuticals Inc.Meprobamate
Alembic Pharmaceuticals LimitedMEPROBAMATE
Avera McKennan HospitalMeprobamate
Dr.Reddy’s Laboratories LimitedMeprobamate
Heritage Pharmaceuticals Inc.Meprobamate
Taro Pharmaceutical Industries Ltd.Meprobamate
Taro Pharmaceuticals U.S.A., Inc.Meprobamate
Watson Laboratories, Inc.Meprobamate